Overview

Biosynex Pharma, founded in 2005 and headquartered in Illkirch, Alsace, France, makes rapid diagnostic tests, in-vitro diagnostic solutions, medical devices such as thermometers and pulse oximeters, and biological reagents. It employs between 200 and 500 people, reports revenue in the 209.9M band, and is publicly listed on Euronext Paris under the ticker ALBIO. The company serves healthcare, laboratory, and research customers, and in October 2026 its US subsidiary received a $6 million award to develop a panel assay for biothreat detection.

At a glance

What Biosynex Pharma makes

The company holds ISO 13485 and ISO 9001 certifications and lists rapid diagnostic tests, medical devices, and laboratory reagents among its products.

Certifications

Biosynex Pharma is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — biosynex.com

• ISO 9001 — biosynex.com

Latest developments

• 2026-10-31 — Alsace. Menaces biologiques : un financement de 5,7 millions de dollars pour une filiale américaine de Biosynex (lalsace.fr)

• 2026-10-30 — L'Avenir (lavenir.net)

• 2026-10-26 — Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MarketScreener (marketscreener.com)

• 2026-10-12 — BIOSYNEX SA: BIOSYNEX annonce sa sortie de procédure de sauvegarde à la suite de l’arrêté de son plan de sauvegarde par le Tribunal Judiciaire de Strasbourg en date du 12 octobre 2026 | FR Regulatory - EQS News (eqs-news.com)

• 2026-06-11 — BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA ... (eqs-news.com)

• 2026-06-01 — WMS IzyPro & Sparck Technologies chez Biosynex | ACSEP (acsep.com)

Company details

Biosynex is a publicly traded company on Euronext Paris, with a workforce of 200 to 500 employees and a reported revenue band of 209.9M. Biosynex Pharma was founded in 2005, has an estimated 200-500 employees, and is headquartered in Illkirch, Alsace. On the LightSource stability read it is rated "Established & strong": 21 years in operation (founded 2005). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Biosynex Pharma do?

Biosynex Pharma, founded in 2005 and headquartered in Illkirch, Alsace, France, makes rapid diagnostic tests, in-vitro diagnostic solutions, medical devices such as thermometers and pulse oximeters, and biological reagents. It employs between 200 and 500 people, reports revenue in the 209.9M band, and is publicly listed on Euronext Paris under the ticker ALBIO. The company serves healthcare, laboratory, and research customers, and in October 2026 its US subsidiary received a $6 million award to develop a panel assay for biothreat detection.

Where is Biosynex Pharma headquartered?

Biosynex Pharma is headquartered in Illkirch, Alsace (Boulevard Sebastien Brant, Illkirch, Alsace, 67400).

When was Biosynex Pharma founded?

Biosynex Pharma was founded in 2005.

How big is Biosynex Pharma?

Biosynex Pharma has an estimated 200-500 employees, with revenue in the 209.9M range.

Is Biosynex Pharma publicly traded?

Publicly traded (OTHER: ALBIO). Public financial figures are drawn from its filings.

What certifications does Biosynex Pharma hold?

Biosynex Pharma lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• A&K Railroad Materials, Inc.

• A&T Europe Spa

• A.Celli Group

• AAC Clyde Space

• Abiogen Pharma S.P.A.

Last verified Nov 2026. Is this your company? Request a correction.